Read the latest information about our research program and global research developments.
Important Update on the Sanfilippo Children's Foundation
Improving communication in Sanfilippo - and how families can...
Study into speech and language in Sanfilippo
Sanfilippo syndrome behavioural symptoms can benefit from pe...
A fifth subtype of Sanfilippo?
A comparison of gut microbiomes provides clues into GI sympt...
Research into the effects of different gene therapy routes o...
The impact of infection on neurodegeneration in Sanfilippo
The impact of Sanfilippo on the respiratory system
Australian Government says Sanfilippo syndrome is not ready ...
Research into new gene therapy technology for Sanfilippo typ...
Heparan Sulfate accepted as a biomarker to support Sanfilipp...
Research on light therapy in a Sanfilippo mouse model
Results from the Anakinra Phase I/II trial for Sanfilippo ha...
2024 Solving Sanfilippo Symposium - a meeting of minds
Stem cell transplantation in a mouse model of Sanfilippo typ...
Loss of brain ‘white matter’ in Sanfilippo
Connecting with the global MPS community
Fruit flies shed light on ultra-rare Sanfilippo syndrome typ...
Four new projects for Sanfilippo syndrome research commence ...
Profile a Sanfilippo Researcher: Ella McDonald
WORLDSymposium 2024 updates
A new global alliance for Sanfilippo syndrome
Profile a Sanfilippo Researcher: Ewan Gerken
Inaugural Australian Lysosomal Disease Summit
Insights into the economic impact of Sanfilippo syndrome
Diverting heparan sulfate breakdown to help treat Sanfilippo
Biomarkers for Sanfilippo
Managing behavioural symptoms in Sanfilippo syndrome
Cutting up antibodies may help improve access to gene therap...
2023 Solving Sanfilippo Symposium - the power of a gathering
Dr Emma Parkinson-Lawrence
Investigating vision loss in Sanfilippo type C mice
Sanfilippo syndrome Brain in a Dish project to continue with...
WORLDsymposium 2023 updates
Overcoming the blood-brain barrier: therapy delivery for San...
Gene-corrected neural stem cells show promise in Sanfilippo ...
Can resveratrol activate autophagy in Sanfilippo?
The Year in Review: a year of progress and achievements
Congratulations, Professor Ian Alexander!
Profile a Sanfilippo Researcher: A/Prof. Jan Kaslin
Towards an enzyme replacement therapy for Sanfilippo type B ...
The first-ever global consensus clinical care guidelines for...
New research describes potential cause of wasting and energy...
High GAG levels impact the cell cycle in Sanfilippo and rela...
Natural History Study sheds light on Sanfilippo syndrome typ...
State of play: Development of therapies targeting autophagy ...
Testing optimised gene therapy for Sanfilippo type B
The effects of high heparan sulfate levels in the lung in Sa...
Prof Kim Hemsley and Dr Adeline Lau: Celebrating 20 years wo...
SOBI Sanfilippo type A enzyme replacement trial results publ...
Chaperone therapy shows promise in Sanfilippo type C mouse m...
From misdiagnosis to early diagnosis: can we rewrite the sto...
State of play: Development of therapies targeting neuroinfla...
The importance of caregivers’ perspectives when evaluating...
Clinical trial updates from WORLDSymposium
A study of Fluoxetine in mice with Sanfilippo type A
Brain in a Dish - project update
Exploring gene activity to understand symptoms and severity ...
The impacts of COVID-19-related distance learning on childre...
Prestigious Dementia Australia Fellowship for young Sanfilip...
Proudly launching the Global Roadmap For Sanfilippo Syndrome...
New type A ERT candidate on track for clinical trial
New mouse model helps researchers see into the Sanfilippo ty...
Supporting patients with Sanfilippo using music
Profile a Sanfilippo Researcher: Dr. Elvira De Leonibus
USA team awarded funding to study ultra-rare Sanfilippo type...
Feeding and gut problems in Sanfilippo
A new Sanfilippo brain cell model provides clues on brain dy...
State of play: Development of enzyme replacement therapies f...
Long-term data from a Type A Enzyme Replacement Therapy tria...
Profile a Sanfilippo Researcher: Dr. Maria Francisca Coutinh...
State of play: Development of gene therapies for Sanfilippo
Type B gene therapy trial releases long-term follow-up resul...
Lysosomal storage disorders - 1 in 5,000
Coming at the heparan sulfate problem from the outside
MPS2021 Conference Summary
Profile of a Sanfilippo Researcher: A/Prof Vito Ferro
State of play: Development of substrate reduction therapies ...
State of play: Development of chaperone therapies for Sanfil...
Research helps explain autism-like symptoms in Sanfilippo
Brain signalling in early-stage Sanfilippo: new insights fro...
A Spotlight on Attenuated Sanfilippo
Approaching Sanfilippo from the parent’s perspective
The world’s first zebrafish model of Sanfilippo: a game-ch...
Can measuring the brain help clinical trials for Sanfilippo?
Clues to lung symptoms in Sanfilippo
New research on Sanfilippo type B enzyme replacement therapy
New research shows high rates of hip problems in Sanfilippo ...
Research sheds light on brain health of Sanfilippo carriers
Research update from the 2021 WORLDSymposium
Encouraging results from ongoing gene therapy clinical trial...
Hopes for a new Sanfilippo type A clinical trial
Research spotlight: ERT development for Sanfilippo type D
Speaker opportunity at virtual NORD conference
First study on Sanfilippo caregiver preferences published
Sanfilippo retinal study findings
Orchard Therapeutics reports early results in Sanfilippo cli...
Congratulations, Andrew Shoubridge!
3rd International Conference: Sanfilippo Syndrome & Related ...
Read the latest information about our research program and global research developments.
Improving communication in Sanfilippo - and how families can...
Study into speech and language in Sanfilippo
Sanfilippo syndrome behavioural symptoms can benefit from pe...
A fifth subtype of Sanfilippo?
A comparison of gut microbiomes provides clues into GI sympt...
Research into the effects of different gene therapy routes o...
The impact of infection on neurodegeneration in Sanfilippo
The impact of Sanfilippo on the respiratory system
Australian Government says Sanfilippo syndrome is not ready ...
Research into new gene therapy technology for Sanfilippo typ...
Heparan Sulfate accepted as a biomarker to support Sanfilipp...
Research on light therapy in a Sanfilippo mouse model
Results from the Anakinra Phase I/II trial for Sanfilippo ha...
2024 Solving Sanfilippo Symposium - a meeting of minds
Stem cell transplantation in a mouse model of Sanfilippo typ...
Loss of brain ‘white matter’ in Sanfilippo
Connecting with the global MPS community
Fruit flies shed light on ultra-rare Sanfilippo syndrome typ...
Four new projects for Sanfilippo syndrome research commence ...
Profile a Sanfilippo Researcher: Ella McDonald
WORLDSymposium 2024 updates
A new global alliance for Sanfilippo syndrome
Profile a Sanfilippo Researcher: Ewan Gerken
Inaugural Australian Lysosomal Disease Summit
Insights into the economic impact of Sanfilippo syndrome
Diverting heparan sulfate breakdown to help treat Sanfilippo
Biomarkers for Sanfilippo
Managing behavioural symptoms in Sanfilippo syndrome
Cutting up antibodies may help improve access to gene therap...
2023 Solving Sanfilippo Symposium - the power of a gathering
Dr Emma Parkinson-Lawrence
Investigating vision loss in Sanfilippo type C mice
Sanfilippo syndrome Brain in a Dish project to continue with...
WORLDsymposium 2023 updates
Overcoming the blood-brain barrier: therapy delivery for San...
Gene-corrected neural stem cells show promise in Sanfilippo ...
Can resveratrol activate autophagy in Sanfilippo?
The Year in Review: a year of progress and achievements
Congratulations, Professor Ian Alexander!
Profile a Sanfilippo Researcher: A/Prof. Jan Kaslin
Towards an enzyme replacement therapy for Sanfilippo type B ...
The first-ever global consensus clinical care guidelines for...
New research describes potential cause of wasting and energy...
High GAG levels impact the cell cycle in Sanfilippo and rela...
Natural History Study sheds light on Sanfilippo syndrome typ...
State of play: Development of therapies targeting autophagy ...
Testing optimised gene therapy for Sanfilippo type B
The effects of high heparan sulfate levels in the lung in Sa...
Prof Kim Hemsley and Dr Adeline Lau: Celebrating 20 years wo...
SOBI Sanfilippo type A enzyme replacement trial results publ...
Chaperone therapy shows promise in Sanfilippo type C mouse m...
From misdiagnosis to early diagnosis: can we rewrite the sto...
State of play: Development of therapies targeting neuroinfla...
The importance of caregivers’ perspectives when evaluating...
Clinical trial updates from WORLDSymposium
A study of Fluoxetine in mice with Sanfilippo type A
Brain in a Dish - project update
Exploring gene activity to understand symptoms and severity ...
The impacts of COVID-19-related distance learning on childre...
Prestigious Dementia Australia Fellowship for young Sanfilip...
Proudly launching the Global Roadmap For Sanfilippo Syndrome...
New type A ERT candidate on track for clinical trial
New mouse model helps researchers see into the Sanfilippo ty...
Supporting patients with Sanfilippo using music
Profile a Sanfilippo Researcher: Dr. Elvira De Leonibus
USA team awarded funding to study ultra-rare Sanfilippo type...
Feeding and gut problems in Sanfilippo
A new Sanfilippo brain cell model provides clues on brain dy...
State of play: Development of enzyme replacement therapies f...
Long-term data from a Type A Enzyme Replacement Therapy tria...
Profile a Sanfilippo Researcher: Dr. Maria Francisca Coutinh...
State of play: Development of gene therapies for Sanfilippo
Type B gene therapy trial releases long-term follow-up resul...
Lysosomal storage disorders - 1 in 5,000
Coming at the heparan sulfate problem from the outside
MPS2021 Conference Summary
Profile of a Sanfilippo Researcher: A/Prof Vito Ferro
State of play: Development of substrate reduction therapies ...
State of play: Development of chaperone therapies for Sanfil...
Research helps explain autism-like symptoms in Sanfilippo
Brain signalling in early-stage Sanfilippo: new insights fro...
A Spotlight on Attenuated Sanfilippo
Approaching Sanfilippo from the parent’s perspective
The world’s first zebrafish model of Sanfilippo: a game-ch...
Can measuring the brain help clinical trials for Sanfilippo?
Clues to lung symptoms in Sanfilippo
New research on Sanfilippo type B enzyme replacement therapy
New research shows high rates of hip problems in Sanfilippo ...
Research sheds light on brain health of Sanfilippo carriers
Research update from the 2021 WORLDSymposium
Encouraging results from ongoing gene therapy clinical trial...
Hopes for a new Sanfilippo type A clinical trial
Research spotlight: ERT development for Sanfilippo type D
Speaker opportunity at virtual NORD conference
First study on Sanfilippo caregiver preferences published
Sanfilippo retinal study findings
Orchard Therapeutics reports early results in Sanfilippo cli...
Congratulations, Andrew Shoubridge!
3rd International Conference: Sanfilippo Syndrome & Related ...
World Sanfilippo Awareness Day
Read the latest information about our research program and global research developments.
Improving communication in Sanfilippo - and how families can...
Study into speech and language in Sanfilippo
Sanfilippo syndrome behavioural symptoms can benefit from pe...
A fifth subtype of Sanfilippo?
A comparison of gut microbiomes provides clues into GI sympt...
Research into the effects of different gene therapy routes o...
The impact of infection on neurodegeneration in Sanfilippo
The impact of Sanfilippo on the respiratory system
Australian Government says Sanfilippo syndrome is not ready ...
Research into new gene therapy technology for Sanfilippo typ...
Heparan Sulfate accepted as a biomarker to support Sanfilipp...
Research on light therapy in a Sanfilippo mouse model
Results from the Anakinra Phase I/II trial for Sanfilippo ha...
2024 Solving Sanfilippo Symposium - a meeting of minds
Stem cell transplantation in a mouse model of Sanfilippo typ...
Loss of brain ‘white matter’ in Sanfilippo
Connecting with the global MPS community
Fruit flies shed light on ultra-rare Sanfilippo syndrome typ...
Four new projects for Sanfilippo syndrome research commence ...
Profile a Sanfilippo Researcher: Ella McDonald
WORLDSymposium 2024 updates
A new global alliance for Sanfilippo syndrome
Profile a Sanfilippo Researcher: Ewan Gerken
Inaugural Australian Lysosomal Disease Summit
Insights into the economic impact of Sanfilippo syndrome
Diverting heparan sulfate breakdown to help treat Sanfilippo
Biomarkers for Sanfilippo
Managing behavioural symptoms in Sanfilippo syndrome
Cutting up antibodies may help improve access to gene therap...
2023 Solving Sanfilippo Symposium - the power of a gathering
Dr Emma Parkinson-Lawrence
Investigating vision loss in Sanfilippo type C mice
Sanfilippo syndrome Brain in a Dish project to continue with...
WORLDsymposium 2023 updates
Overcoming the blood-brain barrier: therapy delivery for San...
Gene-corrected neural stem cells show promise in Sanfilippo ...
Can resveratrol activate autophagy in Sanfilippo?
The Year in Review: a year of progress and achievements
Congratulations, Professor Ian Alexander!
Profile a Sanfilippo Researcher: A/Prof. Jan Kaslin
Towards an enzyme replacement therapy for Sanfilippo type B ...
The first-ever global consensus clinical care guidelines for...
New research describes potential cause of wasting and energy...
High GAG levels impact the cell cycle in Sanfilippo and rela...
Natural History Study sheds light on Sanfilippo syndrome typ...
State of play: Development of therapies targeting autophagy ...
Testing optimised gene therapy for Sanfilippo type B
The effects of high heparan sulfate levels in the lung in Sa...
Prof Kim Hemsley and Dr Adeline Lau: Celebrating 20 years wo...
SOBI Sanfilippo type A enzyme replacement trial results publ...
Chaperone therapy shows promise in Sanfilippo type C mouse m...
From misdiagnosis to early diagnosis: can we rewrite the sto...
State of play: Development of therapies targeting neuroinfla...
The importance of caregivers’ perspectives when evaluating...
Clinical trial updates from WORLDSymposium
A study of Fluoxetine in mice with Sanfilippo type A
Brain in a Dish - project update
Exploring gene activity to understand symptoms and severity ...
The impacts of COVID-19-related distance learning on childre...
Prestigious Dementia Australia Fellowship for young Sanfilip...
Proudly launching the Global Roadmap For Sanfilippo Syndrome...
New type A ERT candidate on track for clinical trial
New mouse model helps researchers see into the Sanfilippo ty...
Supporting patients with Sanfilippo using music
Profile a Sanfilippo Researcher: Dr. Elvira De Leonibus
USA team awarded funding to study ultra-rare Sanfilippo type...
Feeding and gut problems in Sanfilippo
A new Sanfilippo brain cell model provides clues on brain dy...
State of play: Development of enzyme replacement therapies f...
Long-term data from a Type A Enzyme Replacement Therapy tria...
Profile a Sanfilippo Researcher: Dr. Maria Francisca Coutinh...
State of play: Development of gene therapies for Sanfilippo
Type B gene therapy trial releases long-term follow-up resul...
Lysosomal storage disorders - 1 in 5,000
Coming at the heparan sulfate problem from the outside
MPS2021 Conference Summary
Profile of a Sanfilippo Researcher: A/Prof Vito Ferro
State of play: Development of substrate reduction therapies ...
State of play: Development of chaperone therapies for Sanfil...
Research helps explain autism-like symptoms in Sanfilippo
Brain signalling in early-stage Sanfilippo: new insights fro...
A Spotlight on Attenuated Sanfilippo
Approaching Sanfilippo from the parent’s perspective
The world’s first zebrafish model of Sanfilippo: a game-ch...
Can measuring the brain help clinical trials for Sanfilippo?
Clues to lung symptoms in Sanfilippo
New research on Sanfilippo type B enzyme replacement therapy
New research shows high rates of hip problems in Sanfilippo ...
Research sheds light on brain health of Sanfilippo carriers
Research update from the 2021 WORLDSymposium
Encouraging results from ongoing gene therapy clinical trial...
Hopes for a new Sanfilippo type A clinical trial
Research spotlight: ERT development for Sanfilippo type D
Speaker opportunity at virtual NORD conference
First study on Sanfilippo caregiver preferences published
Sanfilippo retinal study findings
Orchard Therapeutics reports early results in Sanfilippo cli...
Congratulations, Andrew Shoubridge!
3rd International Conference: Sanfilippo Syndrome & Related ...
World Sanfilippo Awareness Day
Read the latest information about our research program and global research developments.
Improving communication in Sanfilippo - and how families can...
Study into speech and language in Sanfilippo
Sanfilippo syndrome behavioural symptoms can benefit from pe...
A fifth subtype of Sanfilippo?
A comparison of gut microbiomes provides clues into GI sympt...
Research into the effects of different gene therapy routes o...
The impact of infection on neurodegeneration in Sanfilippo
The impact of Sanfilippo on the respiratory system
Australian Government says Sanfilippo syndrome is not ready ...
Research into new gene therapy technology for Sanfilippo typ...
Heparan Sulfate accepted as a biomarker to support Sanfilipp...
Research on light therapy in a Sanfilippo mouse model
Results from the Anakinra Phase I/II trial for Sanfilippo ha...
2024 Solving Sanfilippo Symposium - a meeting of minds
Stem cell transplantation in a mouse model of Sanfilippo typ...
Loss of brain ‘white matter’ in Sanfilippo
Connecting with the global MPS community
Fruit flies shed light on ultra-rare Sanfilippo syndrome typ...
Four new projects for Sanfilippo syndrome research commence ...
Profile a Sanfilippo Researcher: Ella McDonald
WORLDSymposium 2024 updates
A new global alliance for Sanfilippo syndrome
Profile a Sanfilippo Researcher: Ewan Gerken
Inaugural Australian Lysosomal Disease Summit
Insights into the economic impact of Sanfilippo syndrome
Diverting heparan sulfate breakdown to help treat Sanfilippo
Biomarkers for Sanfilippo
Managing behavioural symptoms in Sanfilippo syndrome
Cutting up antibodies may help improve access to gene therap...
2023 Solving Sanfilippo Symposium - the power of a gathering
Dr Emma Parkinson-Lawrence
Investigating vision loss in Sanfilippo type C mice
Sanfilippo syndrome Brain in a Dish project to continue with...
WORLDsymposium 2023 updates
Overcoming the blood-brain barrier: therapy delivery for San...
Gene-corrected neural stem cells show promise in Sanfilippo ...
Can resveratrol activate autophagy in Sanfilippo?
The Year in Review: a year of progress and achievements
Congratulations, Professor Ian Alexander!
Profile a Sanfilippo Researcher: A/Prof. Jan Kaslin
Towards an enzyme replacement therapy for Sanfilippo type B ...
The first-ever global consensus clinical care guidelines for...
New research describes potential cause of wasting and energy...
High GAG levels impact the cell cycle in Sanfilippo and rela...
Natural History Study sheds light on Sanfilippo syndrome typ...
State of play: Development of therapies targeting autophagy ...
Testing optimised gene therapy for Sanfilippo type B
The effects of high heparan sulfate levels in the lung in Sa...
Prof Kim Hemsley and Dr Adeline Lau: Celebrating 20 years wo...
SOBI Sanfilippo type A enzyme replacement trial results publ...
Chaperone therapy shows promise in Sanfilippo type C mouse m...
From misdiagnosis to early diagnosis: can we rewrite the sto...
State of play: Development of therapies targeting neuroinfla...
The importance of caregivers’ perspectives when evaluating...
Clinical trial updates from WORLDSymposium
A study of Fluoxetine in mice with Sanfilippo type A
Brain in a Dish - project update
Exploring gene activity to understand symptoms and severity ...
The impacts of COVID-19-related distance learning on childre...
Prestigious Dementia Australia Fellowship for young Sanfilip...
Proudly launching the Global Roadmap For Sanfilippo Syndrome...
New type A ERT candidate on track for clinical trial
New mouse model helps researchers see into the Sanfilippo ty...
Supporting patients with Sanfilippo using music
Profile a Sanfilippo Researcher: Dr. Elvira De Leonibus
USA team awarded funding to study ultra-rare Sanfilippo type...
Feeding and gut problems in Sanfilippo
A new Sanfilippo brain cell model provides clues on brain dy...
State of play: Development of enzyme replacement therapies f...
Long-term data from a Type A Enzyme Replacement Therapy tria...
Profile a Sanfilippo Researcher: Dr. Maria Francisca Coutinh...
State of play: Development of gene therapies for Sanfilippo
Type B gene therapy trial releases long-term follow-up resul...
Lysosomal storage disorders - 1 in 5,000
Coming at the heparan sulfate problem from the outside
MPS2021 Conference Summary
Profile of a Sanfilippo Researcher: A/Prof Vito Ferro
State of play: Development of substrate reduction therapies ...
State of play: Development of chaperone therapies for Sanfil...
Research helps explain autism-like symptoms in Sanfilippo
Brain signalling in early-stage Sanfilippo: new insights fro...
A Spotlight on Attenuated Sanfilippo
Approaching Sanfilippo from the parent’s perspective
The world’s first zebrafish model of Sanfilippo: a game-ch...
Can measuring the brain help clinical trials for Sanfilippo?
Clues to lung symptoms in Sanfilippo
New research on Sanfilippo type B enzyme replacement therapy
New research shows high rates of hip problems in Sanfilippo ...
Research sheds light on brain health of Sanfilippo carriers
Research update from the 2021 WORLDSymposium
Encouraging results from ongoing gene therapy clinical trial...
Hopes for a new Sanfilippo type A clinical trial
Research spotlight: ERT development for Sanfilippo type D
Speaker opportunity at virtual NORD conference
First study on Sanfilippo caregiver preferences published
Sanfilippo retinal study findings
Orchard Therapeutics reports early results in Sanfilippo cli...
Congratulations, Andrew Shoubridge!
3rd International Conference: Sanfilippo Syndrome & Related ...
World Sanfilippo Awareness Day
Read the latest information about our research program and global research developments.
Improving communication in Sanfilippo - and how families can...
Study into speech and language in Sanfilippo
Sanfilippo syndrome behavioural symptoms can benefit from pe...
A fifth subtype of Sanfilippo?
A comparison of gut microbiomes provides clues into GI sympt...
Research into the effects of different gene therapy routes o...
The impact of infection on neurodegeneration in Sanfilippo
The impact of Sanfilippo on the respiratory system
Australian Government says Sanfilippo syndrome is not ready ...
Research into new gene therapy technology for Sanfilippo typ...
Heparan Sulfate accepted as a biomarker to support Sanfilipp...
Research on light therapy in a Sanfilippo mouse model
Results from the Anakinra Phase I/II trial for Sanfilippo ha...
2024 Solving Sanfilippo Symposium - a meeting of minds
Stem cell transplantation in a mouse model of Sanfilippo typ...
Loss of brain ‘white matter’ in Sanfilippo
Connecting with the global MPS community
Fruit flies shed light on ultra-rare Sanfilippo syndrome typ...
Four new projects for Sanfilippo syndrome research commence ...
Profile a Sanfilippo Researcher: Ella McDonald
WORLDSymposium 2024 updates
A new global alliance for Sanfilippo syndrome
Profile a Sanfilippo Researcher: Ewan Gerken
Inaugural Australian Lysosomal Disease Summit
Insights into the economic impact of Sanfilippo syndrome
Diverting heparan sulfate breakdown to help treat Sanfilippo
Biomarkers for Sanfilippo
Managing behavioural symptoms in Sanfilippo syndrome
Cutting up antibodies may help improve access to gene therap...
2023 Solving Sanfilippo Symposium - the power of a gathering
Dr Emma Parkinson-Lawrence
Investigating vision loss in Sanfilippo type C mice
Sanfilippo syndrome Brain in a Dish project to continue with...
WORLDsymposium 2023 updates
Overcoming the blood-brain barrier: therapy delivery for San...
Gene-corrected neural stem cells show promise in Sanfilippo ...
Can resveratrol activate autophagy in Sanfilippo?
The Year in Review: a year of progress and achievements
Congratulations, Professor Ian Alexander!
Profile a Sanfilippo Researcher: A/Prof. Jan Kaslin
Towards an enzyme replacement therapy for Sanfilippo type B ...
The first-ever global consensus clinical care guidelines for...
New research describes potential cause of wasting and energy...
High GAG levels impact the cell cycle in Sanfilippo and rela...
Natural History Study sheds light on Sanfilippo syndrome typ...
State of play: Development of therapies targeting autophagy ...
Testing optimised gene therapy for Sanfilippo type B
The effects of high heparan sulfate levels in the lung in Sa...
Prof Kim Hemsley and Dr Adeline Lau: Celebrating 20 years wo...
SOBI Sanfilippo type A enzyme replacement trial results publ...
Chaperone therapy shows promise in Sanfilippo type C mouse m...
From misdiagnosis to early diagnosis: can we rewrite the sto...
State of play: Development of therapies targeting neuroinfla...
The importance of caregivers’ perspectives when evaluating...
Clinical trial updates from WORLDSymposium
A study of Fluoxetine in mice with Sanfilippo type A
Brain in a Dish - project update
Exploring gene activity to understand symptoms and severity ...
The impacts of COVID-19-related distance learning on childre...
Prestigious Dementia Australia Fellowship for young Sanfilip...
Proudly launching the Global Roadmap For Sanfilippo Syndrome...
New type A ERT candidate on track for clinical trial
New mouse model helps researchers see into the Sanfilippo ty...
Supporting patients with Sanfilippo using music
Profile a Sanfilippo Researcher: Dr. Elvira De Leonibus
USA team awarded funding to study ultra-rare Sanfilippo type...
Feeding and gut problems in Sanfilippo
A new Sanfilippo brain cell model provides clues on brain dy...
State of play: Development of enzyme replacement therapies f...
Long-term data from a Type A Enzyme Replacement Therapy tria...
Profile a Sanfilippo Researcher: Dr. Maria Francisca Coutinh...
State of play: Development of gene therapies for Sanfilippo
Type B gene therapy trial releases long-term follow-up resul...
Lysosomal storage disorders - 1 in 5,000
Coming at the heparan sulfate problem from the outside
MPS2021 Conference Summary
Profile of a Sanfilippo Researcher: A/Prof Vito Ferro
State of play: Development of substrate reduction therapies ...
State of play: Development of chaperone therapies for Sanfil...
Research helps explain autism-like symptoms in Sanfilippo
Brain signalling in early-stage Sanfilippo: new insights fro...
A Spotlight on Attenuated Sanfilippo
Approaching Sanfilippo from the parent’s perspective
The world’s first zebrafish model of Sanfilippo: a game-ch...
Can measuring the brain help clinical trials for Sanfilippo?
Clues to lung symptoms in Sanfilippo
New research on Sanfilippo type B enzyme replacement therapy
New research shows high rates of hip problems in Sanfilippo ...
Research sheds light on brain health of Sanfilippo carriers
Research update from the 2021 WORLDSymposium
Encouraging results from ongoing gene therapy clinical trial...
Hopes for a new Sanfilippo type A clinical trial
Research spotlight: ERT development for Sanfilippo type D
Speaker opportunity at virtual NORD conference
First study on Sanfilippo caregiver preferences published
Sanfilippo retinal study findings
Orchard Therapeutics reports early results in Sanfilippo cli...
Congratulations, Andrew Shoubridge!
3rd International Conference: Sanfilippo Syndrome & Related ...
World Sanfilippo Awareness Day
Read the latest information about our research program and global research developments.
Improving communication in Sanfilippo - and how families can...
Study into speech and language in Sanfilippo
Sanfilippo syndrome behavioural symptoms can benefit from pe...
A fifth subtype of Sanfilippo?
A comparison of gut microbiomes provides clues into GI sympt...
Research into the effects of different gene therapy routes o...
The impact of infection on neurodegeneration in Sanfilippo
The impact of Sanfilippo on the respiratory system
Australian Government says Sanfilippo syndrome is not ready ...
Research into new gene therapy technology for Sanfilippo typ...
Heparan Sulfate accepted as a biomarker to support Sanfilipp...
Research on light therapy in a Sanfilippo mouse model
Results from the Anakinra Phase I/II trial for Sanfilippo ha...
2024 Solving Sanfilippo Symposium - a meeting of minds
Stem cell transplantation in a mouse model of Sanfilippo typ...
Loss of brain ‘white matter’ in Sanfilippo
Connecting with the global MPS community
Fruit flies shed light on ultra-rare Sanfilippo syndrome typ...
Four new projects for Sanfilippo syndrome research commence ...
Profile a Sanfilippo Researcher: Ella McDonald
WORLDSymposium 2024 updates
A new global alliance for Sanfilippo syndrome
Profile a Sanfilippo Researcher: Ewan Gerken
Inaugural Australian Lysosomal Disease Summit
Insights into the economic impact of Sanfilippo syndrome
Diverting heparan sulfate breakdown to help treat Sanfilippo
Biomarkers for Sanfilippo
Managing behavioural symptoms in Sanfilippo syndrome
Cutting up antibodies may help improve access to gene therap...
2023 Solving Sanfilippo Symposium - the power of a gathering
Dr Emma Parkinson-Lawrence
Investigating vision loss in Sanfilippo type C mice
Sanfilippo syndrome Brain in a Dish project to continue with...
WORLDsymposium 2023 updates
Overcoming the blood-brain barrier: therapy delivery for San...
Gene-corrected neural stem cells show promise in Sanfilippo ...
Can resveratrol activate autophagy in Sanfilippo?
The Year in Review: a year of progress and achievements
Congratulations, Professor Ian Alexander!
Profile a Sanfilippo Researcher: A/Prof. Jan Kaslin
Towards an enzyme replacement therapy for Sanfilippo type B ...
The first-ever global consensus clinical care guidelines for...
New research describes potential cause of wasting and energy...
High GAG levels impact the cell cycle in Sanfilippo and rela...
Natural History Study sheds light on Sanfilippo syndrome typ...
State of play: Development of therapies targeting autophagy ...
Testing optimised gene therapy for Sanfilippo type B
The effects of high heparan sulfate levels in the lung in Sa...
Prof Kim Hemsley and Dr Adeline Lau: Celebrating 20 years wo...
SOBI Sanfilippo type A enzyme replacement trial results publ...
Chaperone therapy shows promise in Sanfilippo type C mouse m...
From misdiagnosis to early diagnosis: can we rewrite the sto...
State of play: Development of therapies targeting neuroinfla...
The importance of caregivers’ perspectives when evaluating...
Clinical trial updates from WORLDSymposium
A study of Fluoxetine in mice with Sanfilippo type A
Brain in a Dish - project update
Exploring gene activity to understand symptoms and severity ...
The impacts of COVID-19-related distance learning on childre...
Prestigious Dementia Australia Fellowship for young Sanfilip...
Proudly launching the Global Roadmap For Sanfilippo Syndrome...
New type A ERT candidate on track for clinical trial
New mouse model helps researchers see into the Sanfilippo ty...
Supporting patients with Sanfilippo using music
Profile a Sanfilippo Researcher: Dr. Elvira De Leonibus
USA team awarded funding to study ultra-rare Sanfilippo type...
Feeding and gut problems in Sanfilippo
A new Sanfilippo brain cell model provides clues on brain dy...
State of play: Development of enzyme replacement therapies f...
Long-term data from a Type A Enzyme Replacement Therapy tria...
Profile a Sanfilippo Researcher: Dr. Maria Francisca Coutinh...
State of play: Development of gene therapies for Sanfilippo
Type B gene therapy trial releases long-term follow-up resul...
Lysosomal storage disorders - 1 in 5,000
Coming at the heparan sulfate problem from the outside
MPS2021 Conference Summary
Profile of a Sanfilippo Researcher: A/Prof Vito Ferro
State of play: Development of substrate reduction therapies ...
State of play: Development of chaperone therapies for Sanfil...
Research helps explain autism-like symptoms in Sanfilippo
Brain signalling in early-stage Sanfilippo: new insights fro...
A Spotlight on Attenuated Sanfilippo
Approaching Sanfilippo from the parent’s perspective
The world’s first zebrafish model of Sanfilippo: a game-ch...
Can measuring the brain help clinical trials for Sanfilippo?
Clues to lung symptoms in Sanfilippo
New research on Sanfilippo type B enzyme replacement therapy
New research shows high rates of hip problems in Sanfilippo ...
Research sheds light on brain health of Sanfilippo carriers
Research update from the 2021 WORLDSymposium
Encouraging results from ongoing gene therapy clinical trial...
Hopes for a new Sanfilippo type A clinical trial
Research spotlight: ERT development for Sanfilippo type D
Speaker opportunity at virtual NORD conference
First study on Sanfilippo caregiver preferences published
Sanfilippo retinal study findings
Orchard Therapeutics reports early results in Sanfilippo cli...
Congratulations, Andrew Shoubridge!
3rd International Conference: Sanfilippo Syndrome & Related ...
World Sanfilippo Awareness Day
Read the latest information about our research program and global research developments.
Improving communication in Sanfilippo - and how families can...
Study into speech and language in Sanfilippo
Sanfilippo syndrome behavioural symptoms can benefit from pe...
A fifth subtype of Sanfilippo?
A comparison of gut microbiomes provides clues into GI sympt...
Research into the effects of different gene therapy routes o...
The impact of infection on neurodegeneration in Sanfilippo
The impact of Sanfilippo on the respiratory system
Australian Government says Sanfilippo syndrome is not ready ...
Research into new gene therapy technology for Sanfilippo typ...
Heparan Sulfate accepted as a biomarker to support Sanfilipp...
Research on light therapy in a Sanfilippo mouse model
Results from the Anakinra Phase I/II trial for Sanfilippo ha...
2024 Solving Sanfilippo Symposium - a meeting of minds
Stem cell transplantation in a mouse model of Sanfilippo typ...
Loss of brain ‘white matter’ in Sanfilippo
Connecting with the global MPS community
Fruit flies shed light on ultra-rare Sanfilippo syndrome typ...
Four new projects for Sanfilippo syndrome research commence ...
Profile a Sanfilippo Researcher: Ella McDonald
WORLDSymposium 2024 updates
A new global alliance for Sanfilippo syndrome
Profile a Sanfilippo Researcher: Ewan Gerken
Inaugural Australian Lysosomal Disease Summit
Insights into the economic impact of Sanfilippo syndrome
Diverting heparan sulfate breakdown to help treat Sanfilippo
Biomarkers for Sanfilippo
Managing behavioural symptoms in Sanfilippo syndrome
Cutting up antibodies may help improve access to gene therap...
2023 Solving Sanfilippo Symposium - the power of a gathering
Dr Emma Parkinson-Lawrence
Investigating vision loss in Sanfilippo type C mice
Sanfilippo syndrome Brain in a Dish project to continue with...
WORLDsymposium 2023 updates
Overcoming the blood-brain barrier: therapy delivery for San...
Gene-corrected neural stem cells show promise in Sanfilippo ...
Can resveratrol activate autophagy in Sanfilippo?
The Year in Review: a year of progress and achievements
Congratulations, Professor Ian Alexander!
Profile a Sanfilippo Researcher: A/Prof. Jan Kaslin
Towards an enzyme replacement therapy for Sanfilippo type B ...
The first-ever global consensus clinical care guidelines for...
New research describes potential cause of wasting and energy...
High GAG levels impact the cell cycle in Sanfilippo and rela...
Natural History Study sheds light on Sanfilippo syndrome typ...
State of play: Development of therapies targeting autophagy ...
Testing optimised gene therapy for Sanfilippo type B
The effects of high heparan sulfate levels in the lung in Sa...
Prof Kim Hemsley and Dr Adeline Lau: Celebrating 20 years wo...
SOBI Sanfilippo type A enzyme replacement trial results publ...
Chaperone therapy shows promise in Sanfilippo type C mouse m...
From misdiagnosis to early diagnosis: can we rewrite the sto...
State of play: Development of therapies targeting neuroinfla...
The importance of caregivers’ perspectives when evaluating...
Clinical trial updates from WORLDSymposium
A study of Fluoxetine in mice with Sanfilippo type A
Brain in a Dish - project update
Exploring gene activity to understand symptoms and severity ...
The impacts of COVID-19-related distance learning on childre...
Prestigious Dementia Australia Fellowship for young Sanfilip...
Proudly launching the Global Roadmap For Sanfilippo Syndrome...
New type A ERT candidate on track for clinical trial
New mouse model helps researchers see into the Sanfilippo ty...
Supporting patients with Sanfilippo using music
Profile a Sanfilippo Researcher: Dr. Elvira De Leonibus
USA team awarded funding to study ultra-rare Sanfilippo type...
Feeding and gut problems in Sanfilippo
A new Sanfilippo brain cell model provides clues on brain dy...
State of play: Development of enzyme replacement therapies f...
Long-term data from a Type A Enzyme Replacement Therapy tria...
Profile a Sanfilippo Researcher: Dr. Maria Francisca Coutinh...
State of play: Development of gene therapies for Sanfilippo
Type B gene therapy trial releases long-term follow-up resul...
Lysosomal storage disorders - 1 in 5,000
Coming at the heparan sulfate problem from the outside
MPS2021 Conference Summary
Profile of a Sanfilippo Researcher: A/Prof Vito Ferro
State of play: Development of substrate reduction therapies ...
State of play: Development of chaperone therapies for Sanfil...
Research helps explain autism-like symptoms in Sanfilippo
Brain signalling in early-stage Sanfilippo: new insights fro...
A Spotlight on Attenuated Sanfilippo
Approaching Sanfilippo from the parent’s perspective
The world’s first zebrafish model of Sanfilippo: a game-ch...
Can measuring the brain help clinical trials for Sanfilippo?
Clues to lung symptoms in Sanfilippo
New research on Sanfilippo type B enzyme replacement therapy
New research shows high rates of hip problems in Sanfilippo ...
Research sheds light on brain health of Sanfilippo carriers
Research update from the 2021 WORLDSymposium
Encouraging results from ongoing gene therapy clinical trial...
Hopes for a new Sanfilippo type A clinical trial
Research spotlight: ERT development for Sanfilippo type D
Speaker opportunity at virtual NORD conference
First study on Sanfilippo caregiver preferences published
Sanfilippo retinal study findings
Orchard Therapeutics reports early results in Sanfilippo cli...
Congratulations, Andrew Shoubridge!
3rd International Conference: Sanfilippo Syndrome & Related ...
World Sanfilippo Awareness Day
Read the latest information about our research program and global research developments.